EndoCells Overview

  • Year Founded
  • 2004

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 5

Employees

  • Latest Deal Type
  • M&A

EndoCells General Information

Description

Developer of a novel proprietary pancreatic beta islet cell immortalization technology intended to focus on the generation and development of human endocrine cell lines. The company's technology platform allows the generation and development of human endocrine cell lines for drug screening and cell transplantation therapy of Type 1 diabetes, providing laboratories and industries with human beta cell lines for research, drug discovery, development and cell therapy.

Contact Information

Website
www.endocells.com
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 216 Boulevard Saint Germain
  • 75007 Paris
  • France
Primary Industry
Biotechnology
Other Industries
Laboratory Services (Healthcare)
Other Healthcare Services
Acquirer
Univercell Biosolutions
Corporate Office
  • 216 Boulevard Saint Germain
  • 75007 Paris
  • France

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

EndoCells Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Merger/Acquisition 01-Dec-2015 Completed Generating Revenue
1. Early Stage VC Completed Startup
To view EndoCells’s complete valuation and funding history, request access »

EndoCells Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

EndoCells Former Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
Esperante Ventures Corporate Venture Capital Minority
To view EndoCells’s complete investors history, request access »

Ready to get started?

Request a free trial

EndoCells FAQs

  • When was EndoCells founded?

    EndoCells was founded in 2004.

  • Where is EndoCells headquartered?

    EndoCells is headquartered in Paris, France.

  • What is the size of EndoCells?

    EndoCells has 5 total employees.

  • What industry is EndoCells in?

    EndoCells’s primary industry is Biotechnology.

  • Is EndoCells a private or public company?

    EndoCells is a Private company.

  • What is EndoCells’s current revenue?

    The current revenue for EndoCells is .

  • Who are EndoCells’s investors?

    Esperante Ventures has invested in EndoCells.

  • When was EndoCells acquired?

    EndoCells was acquired on 01-Dec-2015.

  • Who acquired EndoCells?

    EndoCells was acquired by Univercell Biosolutions.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »